Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase.
about
Closed-loop insulin delivery for treatment of type 1 diabetes[Fast-acting insulin - new developments towards more flexibility for the patient].Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration.Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidaseUndeniable need for ultrafast-acting insulin: the pediatric perspectiveComparative pharmacokinetics and insulin action for three rapid-acting insulin analogs injected subcutaneously with and without hyaluronidase.Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device.Enhanced absorption of insulin aspart as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients.A review of artificial pancreas technologies with an emphasis on bi-hormonal therapyClinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study.Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.Ultrafast-acting insulins: state of the artInsulin therapies: Current and future trends at dawn.Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.Moving toward the ideal insulin for insulin pumps.Insulin depot formation in subcutaneoue tissue.Closed-loop systems: diversity and natural selection.Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): a 52-week, randomized, treat-to-target, phase 3 trial.Recombinant Human PH20: Baseline Analysis of the Reactive Antibody Prevalence in the General Population Using Healthy Subjects.
P2860
Q27008127-E5660999-FDFC-42AB-A608-12B91AE95697Q30313628-ABC92A16-E048-4C0F-BB28-1E26AD3763F6Q35967897-F928504D-0BD0-427D-8C45-10FD07D596F1Q36229266-4C1269EE-BB0A-4CAE-B2C1-917FF2B993E0Q36229271-91E08E56-567B-4F67-B630-BD23613A316BQ36229282-3663F8DE-262D-4C5D-BD3C-9A6E35E03F19Q36560273-E59EE77A-7E60-4EBA-8C27-B639E14B5BCBQ36609298-29EA09BA-1A0C-4CD9-AE02-BE7781A1ED73Q36720392-74D25DA3-B53B-4C76-9DF5-4E892A80E587Q37154369-46334254-5B1D-42DE-84F7-E7514D157587Q37239321-C550D97C-FA50-457E-AD6E-80E8BE6F3D6EQ37460129-54D241D1-3145-4EC9-9FB8-A2FA31D0DD9BQ38037727-D68214D1-D990-4FC4-8E71-CD85966C0341Q38089594-6EF0031E-A6BC-458D-8AE4-B792E5FBA447Q38205861-22ACFDE8-75B2-4036-A1BF-7C2543E5903BQ38631154-C6514F55-8544-4F1C-BDFB-4A3C900ADB54Q40094432-011E3AFD-9FB4-499E-ABEA-9BA81CBAE3C6Q42412112-89E5C5B9-0282-47D9-B848-2CC0659CBBC0Q47188954-B0681F0B-1C83-4271-98D9-4B993021E84BQ50016364-99900F16-E0A3-482F-A137-DA3CD6AC48DB
P2860
Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@ast
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@en
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@nl
type
label
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@ast
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@en
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@nl
prefLabel
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@ast
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@en
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@nl
P2093
P2860
P356
P1433
P1476
Accelerated insulin pharmacoki ...... l insulins with hyaluronidase.
@en
P2093
Daniel E Vaughn
Douglas B Muchmore
Linda Morrow
P2860
P304
P356
10.2337/DC10-1892
P407
P577
2011-01-27T00:00:00Z